1. Home
  2. VALU vs IMRX Comparison

VALU vs IMRX Comparison

Compare VALU & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Value Line Inc.

VALU

Value Line Inc.

HOLD

Current Price

$40.51

Market Cap

341.6M

Sector

Finance

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$3.72

Market Cap

313.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VALU
IMRX
Founded
1931
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
341.6M
313.8M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
VALU
IMRX
Price
$40.51
$3.72
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $17.17
AVG Volume (30 Days)
1.4K
★ 625.2K
Earning Date
09-14-2026
11-11-2026
Dividend Yield
★ 3.15%
N/A
EPS Growth
4.55
★ 37.75
EPS
★ 0.50
N/A
Revenue
★ $36,257,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$89.58
★ N/A
Revenue Growth
★ 1.08
N/A
52 Week Low
$32.00
$3.74
52 Week High
$44.79
$8.48

Technical Indicators

Market Signals
Indicator
VALU
IMRX
Relative Strength Index (RSI) 67.77 24.84
Support Level $36.31 N/A
Resistance Level N/A $5.32
Average True Range (ATR) 1.25 0.17
MACD 0.44 -0.05
Stochastic Oscillator 83.64 6.57

Price Performance

Historical Comparison
VALU
IMRX

About VALU Value Line Inc.

Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and makes available copyright data, including a ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets its products under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing, and The Most Trusted Name in Investment Research. Its only operating segment is Publishing.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: